Alembic Pharmaceuticals Limited (APLLTD) announced USFDA tentative approval for Darolutamide Tablets, 300 mg, with an estimated market size of US$ 3,155 million.
Metropolis Healthcare Limited (METROPOLIS) reports strong Q4 & FY26 results with revenue up 32% and PAT surging 23%.
Inventurus Knowledge Solutions Limited (IKS) reports robust FY26 financial results with 20% revenue growth and a 48% surge in Profit After Tax.
Lupin Limited (LUPIN) announced U.S. FDA approval for Famotidine Injection, expanding its pharmaceutical portfolio with a bioequivalent to Pepcid®.
Yatharth Hospital & Trauma Care Services Limited (YATHARTH) acquires a new 250-bed hospital in Gurugram, expanding its presence in the high-growth Delhi NCR healthcare market.
OneSource Specialty Pharma Limited (NSE: ONESOURCE) announced strong Q4 FY26 results with revenue up 47% QoQ and EBITDA expanding more than 5x.
Cipla Limited (CIPLA) announced its Q4 FY26 results with robust growth in One India, North America, and One Africa segments.
Sakar Healthcare Limited (SAKAR) records 42% YoY revenue growth in Q4 FY26, with EBITDA rising 67%.
Sagility Limited (NSE: SAGILITY) reports strong FY26 performance with 29.1% revenue growth and 39.5% Adjusted PAT increase.
Sagility Limited (NSE: SAGILITY) reports Q4 FY26 results with 29% revenue growth, driven by AI orchestration and new client wins.